warm autoimmune hemolytic anemia
Showing 1 - 12 of 12
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 21, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 20, 2023
Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
- Obexelimab
- Placebo
- (no location specified)
Mar 24, 2023
Anemia, Hemolytic, Autoimmune Trial (Nipocalimab)
Temporarily not available
- Warm Autoimmune Hemolytic Anemia
- (no location specified)
Nov 15, 2022
Warm Autoimmune Hemolytic Anemia Trial in Worldwide (RVT-1401 680 mg/weekly, RVT-1401 340 mg/weekly)
Terminated
- Warm Autoimmune Hemolytic Anemia
- RVT-1401 680 mg/weekly
- RVT-1401 340 mg/weekly
-
Iowa City, Iowa
- +20 more
Jul 1, 2022
Warm Autoimmune Hemolytic Anemia Trial in Riverside (ALXN1830, Placebo)
Withdrawn
- Warm Autoimmune Hemolytic Anemia
- ALXN1830
- Placebo
-
Riverside, CaliforniaClinical Study Site
Feb 2, 2022
Warm Autoimmune Hemolytic Anemia, Cold Agglutinin Disease Trial in United States (APL-2)
Active, not recruiting
- Warm Autoimmune Hemolytic Anemia
- Cold Agglutinin Disease
-
Whittier, California
- +7 more
Nov 20, 2020
Warm Autoimmune Hemolytic Anemia Trial in Whittier (ALXN1830, Placebo)
Withdrawn
- Warm Autoimmune Hemolytic Anemia
- ALXN1830
- Placebo
-
Whittier, CaliforniaAlexion Study Site
Jul 9, 2020
Warm Autoimmune Hemolytic Anemia Trial in Jordan, United States (ALXN1830)
Terminated
- Warm Autoimmune Hemolytic Anemia
-
Los Angeles, California
- +9 more
May 1, 2020
Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia Trial in Créteil (Ninlaro)
Withdrawn
- Immune Thrombocytopenia
- Warm Autoimmune Hemolytic Anemia
-
Créteil, FranceMahevas
Oct 25, 2019
Warm Autoimmune Hemolytic Anemia Trial in Créteil (rituximab (Mabthera®), Placebo)
Completed
- Warm Autoimmune Hemolytic Anemia
- rituximab (Mabthera®)
- Placebo
-
Créteil, FranceHenri Mondor University Hospital
Oct 18, 2017